Clearside Biomedical, Inc. Annual Depreciation in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Clearside Biomedical, Inc. quarterly/annual Depreciation history and growth rate from 2014 to 2023.
  • Clearside Biomedical, Inc. Depreciation for the quarter ending March 31, 2024 was $28K, a 86.7% increase year-over-year.
  • Clearside Biomedical, Inc. annual Depreciation for 2023 was $67K, a 53.8% decline from 2022.
  • Clearside Biomedical, Inc. annual Depreciation for 2022 was $145K, a 18.5% decline from 2021.
  • Clearside Biomedical, Inc. annual Depreciation for 2021 was $178K, a 1.11% decline from 2020.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $67K -$78K -53.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-12
2022 $145K -$33K -18.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-12
2021 $178K -$2K -1.11% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-12
2020 $180K -$31K -14.7% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-14
2019 $211K +$22K +11.6% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-11
2018 $189K +$7K +3.85% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-15
2017 $182K +$117K +180% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-13
2016 $65K +$5K +8.33% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-15
2015 $60K +$27K +81.8% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-16
2014 $33K Jan 1, 2014 Dec 31, 2014 10-K 2017-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.